132 related articles for article (PubMed ID: 33086103)
21. Association of Cervical Dysbacteriosis, HPV Oncogene Expression, and Cervical Lesion Progression.
Liu H; Liang H; Li D; Wang M; Li Y
Microbiol Spectr; 2022 Oct; 10(5):e0015122. PubMed ID: 36036584
[TBL] [Abstract][Full Text] [Related]
22. Determination of human papillomavirus type in archival tissue specimens of invasive cervical cancer using molecular mapping and E6/E7-based polymerase chain reaction.
Sakamoto J; Saito M; Zhang S; Takakura M; Takagi H; Sasagawa T
PLoS One; 2022; 17(4):e0265996. PubMed ID: 35381047
[TBL] [Abstract][Full Text] [Related]
23. Human Papillomavirus E6/E7 oncogene transcripts as biomarkers for the early detection of cervical cancer.
Gupta SM; Warke H; Chaudhari H; Mavani P; Katke RD; Kerkar SC; Mania-Pramanik J
J Med Virol; 2022 Jul; 94(7):3368-3375. PubMed ID: 35257379
[TBL] [Abstract][Full Text] [Related]
24. HPV E6/E7 mRNA versus HPV DNA biomarker in cervical cancer screening of a group of Macedonian women.
Duvlis S; Popovska-Jankovic K; Arsova ZS; Memeti S; Popeska Z; Plaseska-Karanfilska D
J Med Virol; 2015 Sep; 87(9):1578-86. PubMed ID: 25880030
[TBL] [Abstract][Full Text] [Related]
25. Inactivation of the human papillomavirus E6 or E7 gene in cervical carcinoma cells by using a bacterial CRISPR/Cas RNA-guided endonuclease.
Kennedy EM; Kornepati AV; Goldstein M; Bogerd HP; Poling BC; Whisnant AW; Kastan MB; Cullen BR
J Virol; 2014 Oct; 88(20):11965-72. PubMed ID: 25100830
[TBL] [Abstract][Full Text] [Related]
26. Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus.
Braakhuis BJ; Snijders PJ; Keune WJ; Meijer CJ; Ruijter-Schippers HJ; Leemans CR; Brakenhoff RH
J Natl Cancer Inst; 2004 Jul; 96(13):998-1006. PubMed ID: 15240783
[TBL] [Abstract][Full Text] [Related]
27. Human papillomavirus-related neoplasia of the ocular adnexa.
Ramberg IMS
Acta Ophthalmol; 2022 Oct; 100 Suppl 272(Suppl 272):3-33. PubMed ID: 36203222
[TBL] [Abstract][Full Text] [Related]
28. Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: implications for tumor suppressor gene function in development.
Pan H; Griep AE
Genes Dev; 1994 Jun; 8(11):1285-99. PubMed ID: 7926731
[TBL] [Abstract][Full Text] [Related]
29. Regulation of autophagy by high- and low-risk human papillomaviruses.
Aranda-Rivera AK; Cruz-Gregorio A; Briones-Herrera A; Pedraza-Chaverri J
Rev Med Virol; 2021 Mar; 31(2):e2169. PubMed ID: 33590566
[TBL] [Abstract][Full Text] [Related]
30. Relationship between vaginal microecological changes and oncogene E6/E7 and high-risk human papillomavirus infection.
Huang J; Yin C; Wang J
J Obstet Gynaecol; 2023 Dec; 43(1):2161349. PubMed ID: 36645341
[TBL] [Abstract][Full Text] [Related]
31. Molecular evaluation of human papillomavirus as an oncogenic biomarker in prostate cancer.
Sosse SA; Laraqui A; Mrabti M; Alami M; Mzibri ME; Ennaji MM
Mol Biol Rep; 2023 Jul; 50(7):5719-5724. PubMed ID: 37217619
[TBL] [Abstract][Full Text] [Related]
32. Human Papillomavirus Detected in Oropharyngeal Cancers from Chilean Subjects.
Oliva C; Carrillo-Beltrán D; Boettiger P; Gallegos I; Aguayo F
Viruses; 2022 Jun; 14(6):. PubMed ID: 35746684
[TBL] [Abstract][Full Text] [Related]
33. Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis.
Wang-Johanning F; Lu DW; Wang Y; Johnson MR; Johanning GL
Cancer; 2002 Apr; 94(8):2199-210. PubMed ID: 12001118
[TBL] [Abstract][Full Text] [Related]
34. Variations of human papillomavirus type 58 E6, E7, L1 genes and long control region in strains from women with cervical lesions in Liaoning province, China.
Liu JH; Lu ZT; Wang GL; Zhou WQ; Liu C; Yang LX; Sun ZR; Ruan Q
Infect Genet Evol; 2012 Oct; 12(7):1466-72. PubMed ID: 22659102
[TBL] [Abstract][Full Text] [Related]
35. Molecular mechanism of carcinogenesis by human papillomavirus-16.
Ishiji T
J Dermatol; 2000 Feb; 27(2):73-86. PubMed ID: 10721654
[TBL] [Abstract][Full Text] [Related]
36. Transcription of human papillomavirus oncogenes in head and neck squamous cell carcinomas.
Bzhalava Z; Arroyo Mühr LS; Dillner J
Vaccine; 2020 May; 38(25):4066-4070. PubMed ID: 32362526
[TBL] [Abstract][Full Text] [Related]
37. Use of hTERT and HPV E6/E7 mRNA RT-qPCR TaqMan assays in combination for diagnosing high-grade cervical lesions and malignant tumors.
Wang HY; Park S; Kim S; Lee D; Kim G; Kim Y; Park KH; Lee H
Am J Clin Pathol; 2015 Mar; 143(3):344-51. PubMed ID: 25696792
[TBL] [Abstract][Full Text] [Related]
38. Detection of human papillomavirus (HPV) DNA prevalence and p53 codon 72 (Arg72Pro) polymorphism in prostate cancer in a Greek group of patients.
Michopoulou V; Derdas SP; Symvoulakis E; Mourmouras N; Nomikos A; Delakas D; Sourvinos G; Spandidos DA
Tumour Biol; 2014 Dec; 35(12):12765-73. PubMed ID: 25213701
[TBL] [Abstract][Full Text] [Related]
39. RNA (E6 and E7) assays versus DNA (E6 and E7) assays for risk evaluation for women infected with human papillomavirus.
Cattani P; Siddu A; D'Onghia S; Marchetti S; Santangelo R; Vellone VG; Zannoni GF; Fadda G
J Clin Microbiol; 2009 Jul; 47(7):2136-41. PubMed ID: 19403762
[TBL] [Abstract][Full Text] [Related]
40. In vitro and in vivo growth inhibition of human cervical cancer cells via human papillomavirus E6/E7 mRNAs' cleavage by CRISPR/Cas13a system.
Chen Y; Jiang H; Wang T; He D; Tian R; Cui Z; Tian X; Gao Q; Ma X; Yang J; Wu J; Tan S; Xu H; Tang X; Wang Y; Yu Z; Han H; Das BC; Severinov K; Hitzeroth II; Debata PR; Xu W; Fan W; Jin Z; Cao C; Yu M; Xie W; Huang Z; Hu Z; You Z
Antiviral Res; 2020 Jun; 178():104794. PubMed ID: 32298665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
